Rokit Healthcare, a leading company specializing in organ regeneration (CEO Seok-Hwan You), announced on the 31st that its “Regenerating Kidney” platform was selected as one of the 12 “Strange” Future Technologies by BBC Science Focus at the Middle East’s largest IT expo, GITEX 2023.

GITEX, held annually in Dubai, is one of the world’s largest conferences, showcasing the latest trends in future technologies, including artificial intelligence, robotics, consumer electronics, and smart wearable devices. This year’s exhibition featured a variety of cutting-edge technologies, ranging from football-playing robots to computers embedded in giant shoes and holographic displays.

Rokit Healthcare gained attention at the event for its innovative organ regeneration platform focused on kidney regeneration. A company representative explained, “This technology enables organ regeneration by utilizing autologous fat-derived ECM, artificial intelligence, and 3D printing technology to create regenerative patches. Our organ regeneration technology can be applied to treatments for skin regeneration due to chronic diseases, cartilage restoration in damaged knee bones, and chronic kidney disease treatment.”

Seok-Hwan Yoo, CEO of Rokit Healthcare, stated, “BBC recognized Rokit Healthcare for presenting its innovative organ regeneration technology at GITEX. As our company is increasingly recognized as a first mover in the field of organ regeneration both domestically and internationally, we are committed to driving significant change in this area.”

Meanwhile, Rokit Healthcare’s kidney regeneration technology has been selected as a national advanced regenerative medicine project and is currently in the joint research and development stage with Seoul National University College of Medicine and Asan Medical Center. Additionally, the company’s skin regeneration technology, used to treat difficult-to-heal skin conditions such as diabetic foot ulcers, chronic wounds, and skin cancer, has received usage approval in about 60 countries and is currently being commercialized in approximately 30 countries.